世界と日本の生理活性タンパク質とペプチド市場　2022-2028年

出版：QYResearch（QYリサーチ）　出版年月：2022年12月

Global and Japan Bioactive Protein and Peptides Market Report & Forecast 2022-2028
世界と日本の生理活性タンパク質とペプチド市場報告と予測　2022-2028年

レポート目次　　お問合せ・ご注文　　価格・納期について

Market Analysis and Insights: Global and Japan Bioactive Protein and Peptides Market
This report focuses on global and Japan Bioactive Protein and Peptides market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Bioactive Protein and Peptides market size is estimated to be worth US$ 1,695.84 million in 2022 and is forecast to a readjusted size of US$ 2,533.48 million by 2028 with a CAGR of 6.92% during the review period. Fully considering the economic change by this health crisis, Plant Source accounting for 55.64% of the Bioactive Protein and Peptides global market in 2021, is projected to value US$ 1,480.85 million by 2028, growing at a revised 7.66% CAGR in the post-COVID-19 period. While Dietary Supplements was the leading segment, accounting for over 42.79% percent market share in 2021, and altered to an 7.55% CAGR throughout this forecast period.
In Japan the Bioactive Protein and Peptides market size is expected to grow from US$ 52.35 million in 2021 to US$ 87.17 million by 2028, at a CAGR of 7.75% during the forecast period.
Global Bioactive Protein and Peptides Scope and Market Size
Bioactive Protein and Peptides market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Bioactive Protein and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
For Japan market, this report focuses on the Bioactive Protein and Peptides market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in Japan.

Segment by Type
Plant Source
Animal Source

Segment by Application
Dietary Supplements
Functional Food
Personal Care
Animal Nutrition
Other

By Company
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Rui Biological Technology
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP

By Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
Korea
Australia
South Asia
India

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil
Argentina

Middle East & Africa
GCC Countries
Turkey
South Africa
Egypt

目次

Tables and Figures

1 Study Coverage 1
1.1 Bioactive Protein and Peptides Product Introduction 1
1.2 Global Bioactive Protein and Peptides Outlook, 2017 VS 2022 VS 2028 1
1.2.1 Global Bioactive Protein and Peptides Market Size for the Year 2017-2028 1
1.2.2 Japan Bioactive Protein and Peptides Market Size for the Year 2017-2028 3
1.3 Bioactive Protein and Peptides Market Size, Japan VS Global, 2017 VS 2022 VS 2028 4
1.3.1 The Market Share of Japan Bioactive Protein and Peptides in Global, 2017 VS 2022 VS 2028 4
1.3.2 The Growth Rate of Bioactive Protein and Peptides Market Size, Japan VS Global, 2017 VS 2022 VS 2028 4
1.4 Bioactive Protein and Peptides Market Dynamics 5
1.4.1 Bioactive Protein and Peptides Industry Trends 5
1.4.2 Bioactive Protein and Peptides Market Drivers 5
1.4.3 Bioactive Protein and Peptides Market Challenges 6
1.5 Study Objectives 6
1.6 Years Considered 7
2 Bioactive Protein and Peptides by Type 8
2.1 Bioactive Protein and Peptides Market Segment by Type 8
2.1.1 Plant Source 8
2.1.2 Animal Source 8
2.2 Global Bioactive Protein and Peptides Market Size by Type (2017, 2022 & 2028) 9
2.3 Global Bioactive Protein and Peptides Market Size by Type (2017-2028) 10
2.4 Japan Bioactive Protein and Peptides Market Size by Type (2017, 2022 & 2028) 11
2.5 Japan Bioactive Protein and Peptides Market Size by Type (2017-2028) 12
3 Bioactive Protein and Peptides by Application 13
3.1 Bioactive Protein and Peptides Market Segment by Application 13
3.1.1 Dietary Supplements 13
3.1.2 Functional Food 13
3.1.3 Personal Care 14
3.1.4 Animal Nutrition 14
3.2 Global Bioactive Protein and Peptides Market Size, by Application (2017, 2022 & 2028) 15
3.3 Global Bioactive Protein and Peptides Market Size by Application (2017-2028) 16
3.4 Japan Bioactive Protein and Peptides Market Size by Application (2017, 2022 & 2028) 17
3.5 Japan Bioactive Protein and Peptides Market Size by Application (2017-2028) 18
4 Global Bioactive Protein and Peptides Competitor Landscape by Company 20
4.1 Global Bioactive Protein and Peptides Market Size by Company 20
4.1.1 Top Global Bioactive Protein and Peptides Companies Ranked by Revenue (2021) 20
4.1.2 Global Bioactive Protein and Peptides Revenue by Player (2017-2022) 21
4.2 Global Bioactive Protein and Peptides Concentration Ratio (CR) 22
4.2.1 Bioactive Protein and Peptides Market Concentration Ratio (CR) (2017-2022) 22
4.2.2 Global Top 5 and Top 10 Largest Companies of Bioactive Protein and Peptides in 2021 23
4.2.3 Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24
4.3 Global Bioactive Protein and Peptides Headquarters, Product Type 25
4.3.1 Global Bioactive Protein and Peptides Headquarters and Area Served 25
4.3.2 Global Bioactive Protein and Peptides Companies Product Type 25
4.3.3 Date of International Companies Establishment 26
4.4 Companies Mergers & Acquisitions, Expansion Plans 27
4.5 Japan Bioactive Protein and Peptides Market Size by Company 27
4.5.1 Top Bioactive Protein and Peptides Players in Japan, Ranked by Revenue (2021) 27
4.5.2 Japan Bioactive Protein and Peptides Revenue by Players (2020, 2021 & 2022) 28
5 Global Bioactive Protein and Peptides Market Size by Region 29
5.1 Global Bioactive Protein and Peptides Market Size by Region: 2017 VS 2022 VS 2028 29
5.2 Global Bioactive Protein and Peptides Market Size by Region (2017-2028) 31
5.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2017-2022 31
5.2.2 Global Bioactive Protein and Peptides Market Size by Region: 2023-2028 31
6 Segment in Regional Level & Country Level 33
6.1 North America 33
6.1.1 North America Bioactive Protein and Peptides Market Size YoY Growth 2017-2028 33
6.1.2 North America Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028) 33
6.1.3 U.S. 34
6.1.4 Canada 34
6.2 Asia-Pacific 35
6.2.1 Asia-Pacific Bioactive Protein and Peptides Market Size YoY Growth 2017-2028 35
6.2.2 Asia-Pacific Bioactive Protein and Peptides Market Facts & Figures by Region (2017, 2022 & 2028) 35
6.2.3 China 36
6.2.4 Japan 36
6.2.5 South Korea 37
6.2.6 Australia 37
6.2.7 Southeast Asia 38
6.2.8 India 38
6.3 Europe 39
6.3.1 Europe Bioactive Protein and Peptides Market Size YoY Growth 2017-2028 39
6.3.2 Europe Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028) 39
6.3.3 Germany 40
6.3.4 France 40
6.3.5 U.K. 41
6.3.6 Italy 41
6.3.7 Russia 42
6.4 Latin America 43
6.4.1 Latin America Bioactive Protein and Peptides Market Size YoY Growth 2017-2028 43
6.4.2 Latin America Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028) 43
6.4.3 Brazil 44
6.4.4 Mexico 44
6.4.5 Argentina 45
6.5 Middle East and Africa 46
6.5.1 Middle East and Africa Bioactive Protein and Peptides Market Size YoY Growth 2017-2028 46
6.5.2 Middle East and Africa Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028) 46
6.5.3 GCC Countries 47
6.5.4 Turkey 47
6.5.5 Egypt 48
6.5.6 South Africa 48
7 Key Players Profiles 49
7.1 Gelita 49
7.1.1 Gelita Company Details 49
7.1.2 Gelita Business Overview 49
7.1.3 Gelita Bioactive Protein and Peptides Introduction 50
7.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2017-2022) 50
7.2 Kerry Group 51
7.2.1 Kerry Group Company Details 51
7.2.2 Kerry Group Business Overview 52
7.2.3 Kerry Group Bioactive Protein and Peptides Introduction 52
7.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2017-2022) 53
7.3 Vital Proteins 53
7.3.1 Vital Proteins Company Details 54
7.3.2 Vital Proteins Business Overview 54
7.3.3 Vital Proteins Bioactive Protein and Peptides Introduction 54
7.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2017-2022) 55
7.4 Rousselot 56
7.4.1 Rousselot Company Details 56
7.4.2 Rousselot Business Overview 56
7.4.3 Rousselot Bioactive Protein and Peptides Introduction 57
7.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2017-2022) 57
7.5 BRF Ingredients 58
7.5.1 BRF Ingredients Company Details 58
7.5.2 BRF Ingredients Business Overview 59
7.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction 59
7.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2017-2022) 59
7.6 Bunge Ltd 60
7.6.1 Bunge Ltd Company Details 60
7.6.2 Bunge Ltd Business Overview 61
7.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction 61
7.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2017-2022) 62
7.7 Ingredia Nutritional 63
7.7.1 Ingredia Nutritional Company Details 63
7.7.2 Ingredia Nutritional Business Overview 63
7.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction 63
7.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2017-2022) 64
7.8 Gelatines Weishardt 65
7.8.1 Gelatines Weishardt Company Details 65
7.8.2 Gelatines Weishardt Business Overview 66
7.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction 66
7.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2017-2022) 67
7.9 PanTheryx 68
7.9.1 PanTheryx Company Details 68
7.9.2 PanTheryx Business Overview 68
7.9.3 PanTheryx Bioactive Protein and Peptides Introduction 69
7.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2017-2022) 69
7.10 Hubei Reborn Biotech 70
7.10.1 Hubei Reborn Biotech Company Details 70
7.10.2 Hubei Reborn Biotech Business Overview 71
7.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction 71
7.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022) 71
7.11 Seagarden 72
7.11.1 Seagarden Company Details 72
7.11.2 Seagarden Business Overview 73
7.11.3 Seagarden Bioactive Protein and Peptides Introduction 73
7.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2017-2022) 73
7.12 Shandong Hengxin Biotech 74
7.12.1 Shandong Hengxin Biotech Company Details 74
7.12.2 Shandong Hengxin Biotech Business Overview 75
7.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction 75
7.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022) 76
7.13 Baotou Dongbao Bio-Tech 77
7.13.1 Baotou Dongbao Bio-Tech Company Details 77
7.13.2 Baotou Dongbao Bio-Tech Business Overview 78
7.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction 78
7.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2017-2022) 79
7.14 Wuhan Jiushengtang Biotech 80
7.14.1 Wuhan Jiushengtang Biotech Company Details 80
7.14.2 Wuhan Jiushengtang Biotech Business Overview 81
7.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction 81
7.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022) 82
7.15 Morinaga Milk 83
7.15.1 Morinaga Milk Company Details 83
7.15.2 Morinaga Milk Business Overview 83
7.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction 83
7.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2017-2022) 84
7.16 Collagile 85
7.16.1 Collagile Company Details 85
7.16.2 Collagile Business Overview 85
7.16.3 Collagile Bioactive Protein and Peptides Introduction 85
7.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2017-2022) 86
7.17 Nuritas 87
7.17.1 Nuritas Company Details 87
7.17.2 Nuritas Business Overview 88
7.17.3 Nuritas Bioactive Protein and Peptides Introduction 88
7.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2017-2022) 88
7.17.5 Nuritas Recent Development 89
7.18 SmartPEP 89
7.18.1 SmartPEP Company Details 90
7.18.2 SmartPEP Business Overview 90
7.18.3 SmartPEP Bioactive Protein and Peptides Introduction 90
7.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2017-2022) 91
8 Research Findings and Conclusion 93
9 Appendix 94
9.1 Research Methodology 94
9.1.1 Methodology/Research Approach 94
9.1.2 Data Source 97
9.2 Disclaimer 100
9.3 Author Details 100

Table 1. Bioactive Protein and Peptides Market Size, Japan VS Global, CAGR (2017 VS 2022 VS 2028) 4
Table 2. Bioactive Protein and Peptides Market Trends 5
Table 3. Bioactive Protein and Peptides Market Drivers 5
Table 4. Bioactive Protein and Peptides Market Challenges 6
Table 5. Global Bioactive Protein and Peptides Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) 9
Table 6. Japan Bioactive Protein and Peptides Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) 11
Table 7. Global Bioactive Protein and Peptides Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) 15
Table 8. Japan Bioactive Protein and Peptides Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) 17
Table 9. Top Bioactive Protein and Peptides Companies in Global Market, Ranking by Revenue (2021) 20
Table 10. Global Bioactive Protein and Peptides Revenue by Player, (US$ Million), 2017-2022 21
Table 11. Global Bioactive Protein and Peptides Revenue Share by Player, 2017-2022 21
Table 12. Global Bioactive Protein and Peptides Companies Market Concentration Ratio (CR5) 22
Table 13. Global Bioactive Protein and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2021) 24
Table 14. Top Players of Bioactive Protein and Peptides in Global Market, Headquarters and Area Served 25
Table 15. Global Bioactive Protein and Peptides Companies Product Type 25
Table 16. Date of International Companies Establishment 26
Table 17. Companies Mergers & Acquisitions, Expansion Plans 27
Table 18. Top Bioactive Protein and Peptides Players in Japan Market, Ranking by Revenue (2021) 27
Table 19. Japan Bioactive Protein and Peptides Revenue by Players, (US$ Million), 2020, 2021 & 2022 28
Table 20. Japan Bioactive Protein and Peptides Revenue Share by Players, 2020, 2021 & 2022 28
Table 21. Global Bioactive Protein and Peptides Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 29
Table 22. Global Bioactive Protein and Peptides Market Size by Region (2017-2022) & (US$ Million) 31
Table 23. Global Bioactive Protein and Peptides Market Size Forecast by Region (2023-2028) & (US$ Million) 31
Table 24. North America Bioactive Protein and Peptides Market Size by Country (2017-2028) & (US$ Million) 33
Table 25. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2017-2028) & (US$ Million) 35
Table 26. Europe Bioactive Protein and Peptides Market Size by Country (2017-2028) & (US$ Million) 39
Table 27. Latin America Bioactive Protein and Peptides Market Size by Country (2017-2028) & (US$ Million) 43
Table 28. Middle East and Africa Bioactive Protein and Peptides Market Size by Country (2017-2028) & (US$ Million) 46
Table 29. Gelita Company Details 49
Table 30. Gelita Business Overview 49
Table 31. Gelita Bioactive Protein and Peptides Product 50
Table 32. Gelita Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 50
Table 33. Kerry Group Company Details 51
Table 34. Kerry Group Business Overview 52
Table 35. Kerry Group Bioactive Protein and Peptides Product 52
Table 36. Kerry Group Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 53
Table 37. Vital Proteins Company Details 54
Table 38. Vital Proteins Business Overview 54
Table 39. Vital Proteins Bioactive Protein and Peptides Product 54
Table 40. Vital Proteins Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 55
Table 41. Rousselot Company Details 56
Table 42. Rousselot Business Overview 56
Table 43. Rousselot Bioactive Protein and Peptides Product 57
Table 44. Rousselot Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 57
Table 45. BRF Ingredients Company Details 58
Table 46. BRF Ingredients Business Overview 59
Table 47. BRF Ingredients Bioactive Protein and Peptides Product 59
Table 48. BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 59
Table 49. Bunge Ltd Company Details 60
Table 50. Bunge Ltd Business Overview 61
Table 51. Bunge Ltd Bioactive Protein and Peptides Product 61
Table 52. Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 62
Table 53. Ingredia Nutritional Company Details 63
Table 54. Ingredia Nutritional Business Overview 63
Table 55. Ingredia Nutritional Bioactive Protein and Peptides Product 63
Table 56. Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 64
Table 57. Gelatines Weishardt Company Details 65
Table 58. Gelatines Weishardt Business Overview 66
Table 59. Gelatines Weishardt Bioactive Protein and Peptides Product 66
Table 60. Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 67
Table 61. PanTheryx Company Details 68
Table 62. PanTheryx Business Overview 68
Table 63. PanTheryx Bioactive Protein and Peptides Product 69
Table 64. PanTheryx Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 69
Table 65. Hubei Reborn Biotech Company Details 70
Table 66. Hubei Reborn Biotech Business Overview 71
Table 67. Hubei Reborn Biotech Bioactive Protein and Peptides Product 71
Table 68. Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 71
Table 69. Seagarden Company Details 72
Table 70. Seagarden Business Overview 73
Table 71. Seagarden Bioactive Protein and Peptides Product 73
Table 72. Seagarden Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 73
Table 73. Shandong Hengxin Biotech Company Details 74
Table 74. Shandong Hengxin Biotech Business Overview 75
Table 75. Shandong Hengxin Biotech Bioactive Protein and Peptides Product 75
Table 76. Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 76
Table 77. Baotou Dongbao Bio-Tech Company Details 77
Table 78. Baotou Dongbao Bio-Tech Business Overview 78
Table 79. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product 78
Table 80. Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 79
Table 81. Wuhan Jiushengtang Biotech Company Details 80
Table 82. Wuhan Jiushengtang Biotech Business Overview 81
Table 83. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product 81
Table 84. Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 82
Table 85. Morinaga Milk Company Details 83
Table 86. Morinaga Milk Business Overview 83
Table 87. Morinaga Milk Bioactive Protein and Peptides Product 83
Table 88. Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 84
Table 89. Collagile Company Details 85
Table 90. Collagile Business Overview 85
Table 91. Collagile Bioactive Protein and Peptides Product 85
Table 92. Collagile Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 86
Table 93. Nuritas Company Details 87
Table 94. Nuritas Business Overview 88
Table 95. Nuritas Bioactive Protein and Peptides Product 88
Table 96. Nuritas Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 88
Table 97. Nuritas Recent Development 89
Table 98. SmartPEP Company Details 90
Table 99. SmartPEP Business Overview 90
Table 100. SmartPEP Bioactive Protein and Peptides Product 90
Table 101. SmartPEP Revenue in Bioactive Protein and Peptides Business (2017-2022) & (US$ Million) 91
Table 102. Research Programs/Design for This Report 94
Table 103. Key Data Information from Secondary Sources 97
Table 104. Key Data Information from Primary Sources 99

List of Figures

Figure 1. Bioactive Protein and Peptides Product Picture 1
Figure 2. Global Bioactive Protein and Peptides Market Size, (US$ Million), 2017 VS 2022 VS 2028 2
Figure 3. Global Bioactive Protein and Peptides Market Size 2017-2028 (US$ Million) 2
Figure 4. Japan Bioactive Protein and Peptides Market Size, (US$ Million), 2017 VS 2022 VS 2028 3
Figure 5. Japan Bioactive Protein and Peptides Market Size 2017-2028 (US$ Million) 3
Figure 6. Japan Bioactive Protein and Peptides Market Share in Global 2017-2028 4
Figure 7. Bioactive Protein and Peptides Report Years Considered 7
Figure 8. Product Picture of Plant Source 8
Figure 9. Product Picture of Animal Source 8
Figure 10. Global Bioactive Protein and Peptides Market Share by Type in 2022 & 2028 9
Figure 11. Global Bioactive Protein and Peptides Market Size by Type (2017-2028) & (US$ Million) 10
Figure 12. Global Bioactive Protein and Peptides Market Share by Type (2017-2028) 10
Figure 13. Japan Bioactive Protein and Peptides Market Share by Type in 2022 & 2028 11
Figure 14. Japan Bioactive Protein and Peptides Market Size by Type (2017-2028) & (US$ Million) 12
Figure 15. Japan Bioactive Protein and Peptides Market Share by Type (2017-2028) 12
Figure 16. Product Picture of Dietary Supplements 13
Figure 17. Product Picture of Functional Food 14
Figure 18. Product Picture of Personal Care 14
Figure 19. Product Picture of Animal Nutrition 15
Figure 20. Global Bioactive Protein and Peptides Market Share by Application in 2022 & 2028 16
Figure 21. Global Bioactive Protein and Peptides Market Size by Application (2017-2028) & (US$ Million) 16
Figure 22. Global Bioactive Protein and Peptides Market Share by Application (2017-2028) 17
Figure 23. Japan Bioactive Protein and Peptides Market Share by Application in 2022 & 2028 18
Figure 24. Japan Bioactive Protein and Peptides Market Size by Application (2017-2028) & (US$ Million) 18
Figure 25. Japan Bioactive Protein and Peptides Market Share by Application (2017-2028) 19
Figure 26. The Top 5 Largest Companies of Bioactive Protein and Peptides in the World: Market Share by Bioactive Protein and Peptides Revenue in 2021 23
Figure 27. The Top 10 Largest Companies of Bioactive Protein and Peptides in the World: Market Share by Bioactive Protein and Peptides Revenue in 2021 23
Figure 28. Global Bioactive Protein and Peptides Market Size Market Share by Region: 2017 VS 2022 VS 2028 29
Figure 29. Global Bioactive Protein and Peptides Market Share by Region (2017-2028) 32
Figure 30. North America Bioactive Protein and Peptides Market Size Growth Rate 2017-2028 (US$ Million) 33
Figure 31. U.S. Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 34
Figure 32. Canada Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 34
Figure 33. Asia-Pacific Bioactive Protein and Peptides Market Size Growth Rate 2017-2028 (US$ Million) 35
Figure 34. China Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 36
Figure 35. Japan Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 36
Figure 36. South Korea Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 37
Figure 37. Australia Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 37
Figure 38. Southeast Asia Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 38
Figure 39. India Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 38
Figure 40. Europe Bioactive Protein and Peptides Market Size Growth Rate 2017-2028 (US$ Million) 39
Figure 41. Germany Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 40
Figure 42. France Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 40
Figure 43. U.K. Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 41
Figure 44. Italy Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 41
Figure 45. Russia Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 42
Figure 46. Latin America Bioactive Protein and Peptides Market Size Growth Rate 2017-2028 (US$ Million) 43
Figure 47. Brazil Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 44
Figure 48. Mexico Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 44
Figure 49. Argentina Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 45
Figure 50. Middle East and Africa Bioactive Protein and Peptides Market Size Growth Rate 2017-2028 (US$ Million) 46
Figure 51. GCC Countries Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 47
Figure 52. Turkey Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 47
Figure 53. Egypt Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 48
Figure 54. South Africa Bioactive Protein and Peptides Market Size Growth Rate (2017-2028) & (US$ Million) 48
Figure 55. Gelita Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 51
Figure 56. Kerry Group Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 53
Figure 57. Vital Proteins Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 55
Figure 58. Rousselot Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 58
Figure 59. BRF Ingredients Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 60
Figure 60. Bunge Ltd Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 62
Figure 61. Ingredia Nutritional Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 65
Figure 62. Gelatines Weishardt Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 67
Figure 63. PanTheryx Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 70
Figure 64. Hubei Reborn Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 72
Figure 65. Seagarden Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 74
Figure 66. Shandong Hengxin Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 77
Figure 67. Baotou Dongbao Bio-Tech Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 80
Figure 68. Wuhan Jiushengtang Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 82
Figure 69. Morinaga Milk Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 84
Figure 70. Collagile Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 87
Figure 71. Nuritas Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 89
Figure 72. SmartPEP Revenue Growth Rate in Bioactive Protein and Peptides Business (2017-2022) 92
Figure 73. Bottom-up and Top-down Approaches for This Report 96
Figure 74. Data Triangulation 97
Figure 75. Key Executives Interviewed 99